Reporting Segment Product Linearrow_drop_up Amount (USD) Percentage
keyboard_arrow_right Reporting Segment & Product Line Amount (USD) Percentage
Consumer & Research Services
Genetic, Genomic, and Sequencing Diagnostic Services; Self Paid
These companies operate genetic diagnostic labs. Medical service professionals order diagnostic tests for patients, but the diagnostic services firms bill either the patient directly or through the patient''s insurance provider. The majority of revenue is ultimately derived from patient ''self-pay''.
203.65M 68.00%
Consumer & Research Services
Healthcare Services Platform
These companies provide online platforms that connect patients with doctors.
95.84M 32.00%
Therapeutics
Pre-Revenue Pharmaceuticals
These companies research and develop pharmaceuticals, but do not generate significant revenue. They may eventually market or manufacture their products (pending regulatory approval) or generate revenue through royalties or other means.
Non-Attributed
Non-Attributed help Why Zero? Explanation of what the heck's going on here.
keyboard_arrow_right keyboard_arrow_down
Consumer & Research Services
Genetic, Genomic, and Sequencing Diagnostic Services; Self Paid
203.65M 68.00%
keyboard_arrow_right
These companies operate genetic diagnostic labs. Medical service professionals order diagnostic tests for patients, but the diagnostic services firms bill either the patient directly or through the patient''s insurance provider. The majority of revenue is ultimately derived from patient ''self-pay''.
keyboard_arrow_right keyboard_arrow_down
Consumer & Research Services
Healthcare Services Platform
95.84M 32.00%
keyboard_arrow_right
These companies provide online platforms that connect patients with doctors.
keyboard_arrow_right keyboard_arrow_down
Therapeutics
Pre-Revenue Pharmaceuticals
Non-Attributed
Non-Attributed help Why Zero? Explanation of what the heck's going on here.
keyboard_arrow_right
help Why Zero? Explanation of what the heck's going on here.
These companies research and develop pharmaceuticals, but do not generate significant revenue. They may eventually market or manufacture their products (pending regulatory approval) or generate revenue through royalties or other means.